Incro Pharmaceuticals Corporation

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Incro Pharmaceuticals Corporation - overview

Established

2015

Location

-, CA, US

Primary Industry

Pharmaceuticals

About

Founded in 2015, Incro Pharmaceuticals Corporation is based in Santa Fe, California. The firm operates as a developer of drugs used to block a protein called RIP1.


Current Investors

Denali Therapeutics Inc.

Primary Industry

Pharmaceuticals

Sub Industries

Drug Stores/Convenience Stores, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Incro Pharmaceuticals Corporation - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.